Compare BCRX & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | GNL |
|---|---|---|
| Founded | 1986 | 2011 |
| Country | United States | United States |
| Employees | N/A | 56 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1995 | N/A |
| Metric | BCRX | GNL |
|---|---|---|
| Price | $9.52 | $9.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $20.82 | $9.50 |
| AVG Volume (30 Days) | ★ 5.9M | 1.9M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 8.26% |
| EPS Growth | ★ 381.40 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.55 | N/A |
| P/E Ratio | $7.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $6.51 |
| 52 Week High | $11.31 | $10.04 |
| Indicator | BCRX | GNL |
|---|---|---|
| Relative Strength Index (RSI) | 64.59 | 50.51 |
| Support Level | $7.85 | $9.23 |
| Resistance Level | $10.32 | $9.75 |
| Average True Range (ATR) | 0.60 | 0.20 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 65.44 | 42.95 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operation, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution, Retail, and Office. The company derives maximum revenue from the Industrial and Distribution segment. The company geographically operates in the United States, the United Kingdom, Canada, and Europe.